Baxter
BAX
#1126
Rank
NZ$28.39 B
Marketcap
$55.60
Share price
0.34%
Change (1 day)
-5.72%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$31.70 Billion

According to Baxter's latest financial reports the company's total liabilities are NZ$31.70 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Baxter - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$31.32 B-11.19%
2022-12-31NZ$35.26 B-1.27%
2021-12-31NZ$35.72 B128.24%
2020-12-31NZ$15.65 B2.53%
2019-12-31NZ$15.26 B30.38%
2018-12-31NZ$11.70 B4.01%
2017-12-31NZ$11.25 B7.32%
2016-12-31NZ$10.48 B-40.65%
2015-12-31NZ$17.67 B-22.99%
2014-12-31NZ$22.95 B12.68%
2013-12-31NZ$20.36 B24.93%
2012-12-31NZ$16.30 B3.91%
2011-12-31NZ$15.68 B13.2%
2010-12-31NZ$13.86 B1.34%
2009-12-31NZ$13.67 B-13.5%
2008-12-31NZ$15.81 B44.57%
2007-12-31NZ$10.93 B-8.42%
2006-12-31NZ$11.94 B-3.14%
2005-12-31NZ$12.33 B-15.74%
2004-12-31NZ$14.63 B-8.82%
2003-12-31NZ$16.04 B-11.95%
2002-12-31NZ$18.22 B14.92%
2001-12-31NZ$15.86 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$78.95 B 149.06%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$40.35 B 27.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.17 B-7.97%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$50.63 B 59.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.83 B-91.05%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$87.36 B 175.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.16 B-77.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$70.87 B 123.55%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$3.83 B-87.91%๐Ÿ‡บ๐Ÿ‡ธ USA